Cargando…
Mesenchymal Stem Cells Ameliorate DSS-Induced Experimental Colitis by Modulating the Gut Microbiota and MUC-1 Pathway
PURPOSE: Mesenchymal stem cells (MSCs) have become novel therapeutic agents for the treatment of inflammatory bowel diseases (IBDs). However, the precise cellular and molecular mechanisms by which MSCs restore intestinal tissue homeostasis and repair the epithelial barrier have not been well elucida...
Autores principales: | Wang, Han, Sun, Yang, Xiao, Feng-Jun, Zhao, Xia, Zhang, Wei-Yuan, Xia, Yu-Jun, Wang, Li-Sheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10184855/ https://www.ncbi.nlm.nih.gov/pubmed/37197438 http://dx.doi.org/10.2147/JIR.S402592 |
Ejemplares similares
-
Cinobufacini ameliorates experimental colitis via modulating the composition of gut microbiota
por: Bai, Yongfeng, et al.
Publicado: (2019) -
Mulberry Anthocyanins Ameliorate DSS-Induced Ulcerative Colitis by Improving Intestinal Barrier Function and Modulating Gut Microbiota
por: Mo, Jianling, et al.
Publicado: (2022) -
Pretreatment with Bifidobacterium longum BAA2573 ameliorates dextran sulfate sodium (DSS)-induced colitis by modulating gut microbiota
por: Lin, Qiong, et al.
Publicado: (2023) -
Fecal microbiota transplantation ameliorates experimental colitis via gut microbiota and T-cell modulation
por: Wen, Xin, et al.
Publicado: (2021) -
Bacillus coagulans in Combination with Chitooligosaccharides Regulates Gut Microbiota and Ameliorates the DSS-Induced Colitis in Mice
por: Liu, Zhenzhen, et al.
Publicado: (2022)